Research Collaboration launched with Chinese health firm

03 September 2015

The University of Cambridge has concluded a £4 million agreement with Chinese health firm Infinitus (China) Company Ltd. (Infinitus (China) for short) to explore the activity of plant-derived compounds at the molecular and cellular levels.

Read More

Astrazeneca and Cambridge announce new joint PhD and clinical research scholarships

30 June 2015

AstraZeneca and the University of Cambridge today announced three new joint schemes to support more than 80 PhD scholarships and eight clinical lectureships over the next five years spanning translational science, basic and clinical research. Two of the schemes are co-funded by the NIHR Cambridge Biomedical Research Centre, a partnership between Cambridge University Hospitals and University of Cambridge.

Read More

Pages